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Abstract
Improving the treatment of trauma, a leading cause of death worldwide, is of great clinical
and public health interest. This analysis introduces flexible statistical methods for estimating
center-level effects on individual outcomes in the context of highly variable patient popula-
tions, such as those of the PRospective, Observational, Multi-center Major Trauma Transfu-
sion study. Ten US level I trauma centers enrolled a total of 1,245 trauma patients who
survived at least 30 minutes after admission and received at least one unit of red blood
cells. Outcomes included death, multiple organ failure, substantial bleeding, and transfusion
of blood products. The centers involved were classified as either large or small-volume
based on the number of massive transfusion patients enrolled during the study period. We
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focused on estimation of parameters inspired by causal inference, specifically estimated
impacts on patient outcomes related to the volume of the trauma hospital that treated them.
We defined this association as the change in mean outcomes of interest that would be
observed if, contrary to fact, subjects from large-volume sites were treated at small-volume
sites (the effect of treatment among the treated). We estimated this parameter using three
different methods, some of which use data-adaptive machine learning tools to derive the
outcome models, minimizing residual confounding by reducing model misspecification. Dif-
ferences between unadjusted and adjusted estimators sometimes differed dramatically,
demonstrating the need to account for differences in patient characteristics in clinic compar-
isons. In addition, the estimators based on robust adjustment methods showed potential
impacts of hospital volume. For instance, we estimated a survival benefit for patients who
were treated at large-volume sites, which was not apparent in simpler, unadjusted compari-
sons. By removing arbitrary modeling decisions from the estimation process and concen-
trating on parameters that have more direct policy implications, these potentially automated
approaches allow methodological standardization across similar comparativeness effec-
tiveness studies.
Introduction
Trauma is a leading cause of death worldwide and is an increasing global health burden, rapidly
eclipsing HIV/AIDS, vaso-occlusive and infectious diseases [1,2], and understanding the
underlying mechanisms and improving the treatment of trauma is of paramount clinical and
public health interest. While there is a vast literature exploring the predictors and effects of the
care of injured patients, this research is undertaken on an extremely heterogeneous group of
patients in often austere and chaotic environments including the pre-hospital setting, the bat-
tlefield, the emergency department and the operating room. Confounding is introduced by the
considerable heterogeneity among patients across trauma units, including differences in age,
gender, injury types and severity. Finally, impacts of treatment decisions are often highly con-
founded by current patient health states. Indeed the very measures aimed at saving lives and
improving outcomes often prevent clean separation of patient cohorts and make causal rela-
tionships challenging and sometimes impossible to discern. Missing data is also very prevalent
because of the primacy of patient treatment over collecting data. Randomized controlled trials
(RCTs), which minimize between-group differences and isolate a variable or treatment to be
studied, are optimum, but are rare in trauma due to issues surrounding methodological com-
plexity, issues with informed consent and expense.
There is a vast literature examining the impact of how and where care is delivered on patient
outcomes, including treatment biases (e.g., large volume vs. small volume, urban vs. rural,
American College of Surgeons verified, massive transfusion protocol vs. no massive transfusion
protocol) [3–6]. Addressing the relative importance of center-level factors in the treatment of
trauma is a challenging question, since each center has unique physicians, resources, and patient
types. For example, it would not be fair to compare two centers with different distributions of
baseline injury severity or other confounders. The ideal experiment would consist of one that
could ignore geography and randomize the trauma centers such that an injured patient would
have an equal likelihood of being treated at any center. The average outcomes across centers
could then be compared. Instead, one must resort to statistically estimating such an association
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using available observational data. The bridge between the optimal experiment and the one
available must involve dense data on patient characteristics and statistical methodologies that
can robustly account for confounding differences of patient populations at different clinics.
Our approach described here utilizes two major advances in statistical methodology: (1) tar-
geted data adaptive machine learning tools for modeling clinical outcomes and the distribution
of patients across different trauma centers, given a potentially large number of covariates, and
(2) using the resulting models to estimate parameters that reflect how the site characteristic of
interest affects the distribution of outcomes among the patients. The purpose of this analysis was
to present statistical methodology that can be ultimately available as an automated, data-adap-
tive statistical learner targeted towards the estimation of the impact of center-level characteristics
on patient outcomes; we demonstrate the potential of these approaches on data from the PRo-
spective, Observational, Multi-center Major Trauma Transfusion (PROMMTT) study [7].
Methods
Data: The PRospective, Observational, Multi-center Major Trauma
Transfusion study
The PRospective, Observational Multi-center Major Trauma Transfusion (PROMMTT) study
enrolled 1,245 individuals at ten level I trauma centers from around the United States [8].
Patients had to survive at least 30 minutes and receive at least one unit of red blood cells within
6 hours of arrival in the emergency department (ED) [8]. Once enrolled they were followed for
diagnostic and therapeutic procedures and subsequent outcome data were collected [8]. The
PROMMTT study was approved at each study site and the Data Coordinating Center by the
local institutional review boards. The US Army Human Research Protections Office also pro-
vided secondary level review and approval. Patient records were de-identified prior to their use
in this analysis.
For the purposes of this analysis, we partitioned centers and defined ‘volume’ based on the
number of patients massively transfused, or receiving ten or more units of red blood cells in the
first 24 hours, at each site. The top three massive transfusers were defined as large-volume centers
while the others were defined as small-volume centers. We note that the hospitals could have
been dichotomized by volume in many ways, and so the choice based upon volume of MT is
somewhat arbitrary, and used for illustrative purposes only. Volume varies from a low of 4
patients in one hospital during the study period, to a high of around 80 patients, with no obvious
inflection inMT volume between “large” and “small” groups. Thus, for the remainder of the
paper, “large” versus “small” only refers to relative number of MT patients in this arbitrary group-
ing, with the split point placed between 32 and 33 MT patients, noting the analysis could be
equivalently done for other categorizations, which, in turn, could have led to different estimates.
Only 1,242 of 1,245 PROMMTT patients had sufficient data to analyze and were used for
the analysis. Table 1 shows the distributions of the outcomes of interest and other cohort char-
acteristics in our sample. The three large-volume sites treated 551 individuals while 691 were
treated at the seven small-volume sites.
Model and Parameter of Interest
The goal was to estimate the relationship between patient outcomes and site volume type,
adjusting for a large number of covariates. If we define Y as the outcome, S (large vs. small-vol-
ume site) as the explanatory variable of interest, and C as all confounding variables, we could
predict, on average, what would happen to a patient if they went to a site of a specific size, if we
knew the model:mean(Y | S = s, C). We discuss below how to estimate this prediction function,
Statistical Machines for Trauma Hospital Outcomes Research
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Table 1. Summary statistics. Summaries are presented as percent where indicated, and mean (standard deviation) otherwise.
Small Clinics (n = 691) Large Clinics (n = 551) p^ for difference
Explanatory Variables
Male (%) 73.7 75.1 0.555
Age (years) 42.2 (18.8) 39.0 (18.2) 0.002*
Missing (%) 0 0.18 0.263
Ethnicity (%):
Hispanic/Latino 18.8 19.8 0.667
Non-Hispanic/Latino 75.8 74.2 0.516
Missing 5.35 5.99 0.630
Race (%):
White 74.8 58.1 <0.001*
Black 15.6 20.9 0.017*
Asian/Paciﬁc Islander 3.62 3.99 0.731
Other 3.04 13.25 <0.001*
Missing 2.89 3.81 0.369
BMI (kg/m2) 28.3 (7.16) 27.4 (6.32) 0.028*
Missing (%) 13.6 32.8 <0.001*
ISS 25.9 (15.8) 26.4 (14.5) 0.318
Penetrating injury (%) 31.4 40.1 0.001*
Anticoagulant use (%):
Yes 15.1 7.26 <0.001*
No 59.6 72.8 <0.001*
Missing 25.3 20.0 0.026*
ED Systolic BP (mmHg) 110 (30.4) 106 (32.7) 0.009*
Missing (%) 2.32 2.72 0.648
ED Heart rate (BPM) 106 (27.9) 106 (28.3) 0.761
Missing (%) 2.46 1.63 0.312
ED Glasgow coma score 9.51 (5.62) 10.1 (5.48) 0.195
Missing (%) 9.41 7.99 0.379
ED INR 1.40 (0.776) 1.52 (1.49) 0.064
Missing (%) 15.6 9.98 0.003*
Partial thromboplastin time (s) 32.1 (18.7) 31.6 (16.2) 0.087
Missing (%) 17.9 13.6 0.039*
ED Platelet count (109/L) 223 (82.5) 243 (82.3) <0.001*
Missing (%) 4.92 6.35 0.274
ED Hemoglobin count (g/dL) 11.3 (2.37) 12.1 (2.23) <0.001*
Missing (%) 2.46 5.26 0.009*
ED Base deﬁcit (mEq/L) -7.33 (5.69) -6.70 (5.52) 0.075
Missing (%) 27.4 17.2 <0.001*
Outcomes
Mortality (%):
2-hour 4.49 3.09 0.203
6-hour 8.39 7.99 0.795
24-hour 12.7 10.9 0.318
Overall 21.7 21.1 0.780
Complications (%) 6.66 3.63 0.018*
Multiple organ failure (%) 1.59 1.09 0.449
Substantial bleeding (%):
(Continued)
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going beyond traditional regression approaches and utilizes machine-learning tools. First, how-
ever, we need to define a parameter that is not just a prediction for a specific patient (defined
by their covariates S and C), but an association that summarizes the impact for each patient
across the patient population. For instance, we could define the mean of these predictions,
mean(Y(s)) = mean{mean(Y | S = s, C)}, where the outer mean is taken over all the patients
(and the “natural” distribution of confounders). If the outcome prediction model is correct,
along with important identifiability assumptions outlined below, we could then compare
patient outcomes if, keeping their covariates (C) the same, they went to all large vs. small vol-
ume sites. This parameter,mean(Y(large))−mean(Y(small)), would be a measure of the average
causal association of site size. We chose a slightly different parameter, which examines this dif-
ference only among the people who went to larger sites, ormean{Y(large)−Y(small) | S = large}.
In what sub-group one estimates the causal association is somewhat arbitrary, but in this case
we chose such a parameter because 1) these populations are often quite different, and a param-
eter over the whole study population has little meaning in some theoretical mixed target popu-
lation of large and small hospitals and 2) we wish to have an effect estimate for which one
could compare to a matching procedure discussed below, in which patients at large sites are
paired to patients at small sites based on their characteristics. Our estimand of interest (based
on explicit identifiability assumptions discussed below) is an effect of treatment among the
treated (ETT):
ETT ¼ meanfðmean½Y jS ¼ large;C mean½Y jS ¼ small;CÞjS ¼ largeg: ð1Þ
Estimation: Regression Models
As mentioned above, we do not know the outcome prediction modelmean(Y | S = s, C), nor do
we know how the distribution of center types differs by patient characteristics, Prob(S = large |
C), sometimes called a propensity score, and thus must estimate both functions from the data.
While there are many options for the choice of prediction model to use, in order to make the
most efficient use of available information and to estimate this prediction function using a the-
oretically optimal procedure, we advocate the use of the ensemble machine-learning algorithm
Table 1. (Continued)
Small Clinics (n = 691) Large Clinics (n = 551) p^ for difference
Yes 29.5 30.9 0.612
No 68.2 66.4 0.516
Unknown/Missing 2.32 2.72 0.648
Plasma infused by 24 hr (U) 4.77 (8.57) 7.92 (9.80) <0.001*
Platelets infused by 24 hr (U) 3.77 (7.68) 4.07 (8.34) 0.886
RBC infused by 24 hr (U) 7.91 (10.9) 8.59 (10.5) 0.025*
Platelet:RBC ratio by 24 hr 0.372 (0.934) 0.343 (0.86) 0.805
Missing (%) 0.145 0.181 0.872
Plasma:RBC ratio by 24 hr 0.475 (0.634) 0.946 (0.731) <0.001*
Missing (%) 0.145 0.181 0.872
^ p-values derived from Mann-Whitney U and Z-tests for continuous and binary variables respectively.
* p-value signiﬁcant (α = 0.05).
BMI: body mass index; ISS: injury severity score; BP: blood pressure; BPM: beats per minute; INR: international normalized ratio; RBC: red blood cell; U:
units.
doi:10.1371/journal.pone.0136438.t001
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called SuperLearner (SL). This prediction algorithm consists of a weighted combination of a
library of prediction procedures [9]. We used 10-fold cross-validation where the data were
divided randomly into 10 equal validation samples. One at a time, these validation samples
were “removed” from the data, and prediction algorithms were fit on the remaining 9/10 of the
data (the so-called training sample). Then, for each of these 10 overlapping training samples,
the procedure predicted, for each algorithm, on the independent (independent of the corre-
sponding training sample) validation sample. Finally, the SL procedure found the optimal
weighted average of these predictors by comparing the observed outcomes to those predicted
based on the models from the corresponding training sample. The procedure is more than an
intuitive way to build a prediction model, as theory shows that the SL is guaranteed to perform
as well as or better than the best prediction algorithm in the supplied library [9]. Thus, in
essence one cannot beat SL, because any competing algorithm can be added as one of the can-
didates. Another of the great advantages of this approach is that it takes the art (and thus
potential bias) out of model selection, as the user does not have to choose a particular predic-
tion model but can allow all of them to be competitors, including very simple algorithms, very
complicated machine learners, and even particular models that the researchers prefer. In this
case, the SL builds the final model based on which of them does the best job of predicting a
“new” set of data, so one need not engage in sterile arguments about the best approach to
model such data—in this case “proof is in the pudding”.
Finally, though there was almost no missing values for the outcomes (see Table 1), some of
the covariates have missing values for many of the observations. Instead of using an imputation
approach, we create new basis functions: indicators of whether the variable is not missing (1 if
not missing, 0 if missing, denoted by Δ) and the interaction of each indicator with its respective
covariate (ΔC). The advantage of this approach is that this missingness information is used
directly by the procedure to find the prediction model, so that if the missingness is informative,
and there is sufficient information in the remaining measured variables to explain it relative to
the outcome, then the procedure will find an optimal prediction model. Also, the necessary
identifiability assumptions to get consistent estimates of causal effects under this strategy are
very transparent—that is, the combination of observed covariates and missing data informa-
tion must be sufficient such that there are no further unmeasured pathways related to the set of
explanatory variables we include in the model.
In an observational clinical study like PROMMTT, some covariates of interest almost cer-
tainly remain unobserved due to life-saving measures trumping data collection. Since a
patient’s condition could dictate whether or not information on that patient’s condition was
recorded, missingness not at random (MNAR) cannot be ruled out here. Just as is the case with
the assumption of no unmeasured confounding in observational studies, there is no single solu-
tion and in some circumstances one might conclude that the estimation is hopelessly biased
due to the missing covariates, regardless of the missing data strategy employed. Here, our goal
is to optimally estimate determinants of patient outcomes in the context of the available infor-
mation without manufacturing additional information under potentially unsupported
parametric assumptions. We therefore choose to employ the “indicator method” described
above for any covariates with missing values, reported in Table 1.
Estimation: Effect Estimates
We used several methods to estimate the ETT, the first being a simple substitution estimator
[10], where one first predicts the outcome of interest based on predictors (S and C) to derive an
estimate ofmean{Y | S, C} and subsequently applies this model to predicting the outcome for
subjects if one kept the C fixed, but changed the S to “large.” The average difference among
Statistical Machines for Trauma Hospital Outcomes Research
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these predicted values and the observed outcomes in large volume sites defines the estimate of
the ETT. We did this approach both using an estimated main terms logistic regression model
formean{Y | S, C} (“Simple Subs.(regression)” in Table 2) as well as the same estimator based
upon a SL fit using the SuperLearner [9,11] package in R [12]. For both, we derived the infer-
ence (the standard error) using the nonparametric bootstrap [13]. Though there is no theory
that guarantees this estimator based upon SL has a normal limit distribution, we estimated the
standard error using the nonparametric bootstrap and generated Wald-style confidence inter-
vals (CI). For the estimator based upon main terms logistic regression, we can assume asymp-
totic normality but the CI is still not valid due to bias.
This substitution estimator can be updated to achieve additional bias reduction via a so-
called targeted maximum-likelihood estimation (TMLE) step. The targeting procedure updates
the estimated conditional mean functionsmean{Y | S, C} and Prob(S = large | C) by adding
“clever covariates” to the original respective SL regression fits. In each case, a logistic regression
of the outcome (Y or S) on its respective clever covariate is estimated, with the log-odds of the
previously predicted outcome for each patient serving as an offset. When the procedure con-
verges (meaning that the resulting logistic regression coefficients no longer change measurably
between iterations), the resulting updated functionmean{Y | S, C} can be evaluated at each
level of the treatment to yield a targeted estimate ofmean{Y | S = large, C}−mean{Y | S = small,
C}, evaluated only among those treated at a large volume site. This estimator has additional
desirable statistical properties that the original, non-targeted substitution estimator does not;
the additional step can further reduce bias and results in normally distributed estimators,
whereas the original substitution estimator based upon SL alone is not guaranteed to have a
normal limit distribution (see chapter 8 in [14]).
Finally, the matching estimator uses the SuperLearner to estimate the propensity score,
Prob(S = large | C), and matches each large volume site patient to the closest small volume site
patient based on this score (in this case, with replacement and allowing ties). Any small volume
site patient whose propensity score was not within 0.05 standard deviations of any large vol-
ume site patient’s score was discarded for the purposes of this estimator. Here, the ETT is esti-
mated by the average of the difference in the outcomes among these matched sites [15,16].
We note that the substitution estimator and the matching estimator rely on consistently
estimating the prediction model and propensity score model, respectively. However, the TMLE
relies on only estimating one of these consistently, and thus has greater robustness to model
misspecification than either of these competitors.
Results
We show the bivariate empirical distribution of covariates (C) by site in Table 1. Though this
does not show the differences in the joint distribution of the explanatory variables, there appear
to be important bivariate differences among them; the large hospitals serve a more racially
diverse, younger group of patients who have more penetrating injuries, less baseline use of anti-
coagulants (probably related to the younger age), and higher platelet and hemoglobin counts
observed in the emergency department (ED). There are also statistically significant unadjusted
differences in the mean outcomes in large versus small-volume hospitals, particularly a lower
proportion of complications, more infusion of platelets and RBCs, as well as a higher ratio of
plasma to RBCs. These differences underscore of using estimators that can robustly incorpo-
rate differences in distribution of baseline characteristics in estimates of the marginal impact of
site-level characteristic.
Table 2 contains the estimated unadjusted and adjusted (ETT by various methods) associa-
tions. Complications, for which the unadjusted estimator showed significantly lower rates in
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the larger-volume hospitals, did not significantly differ after adjustment using any of the ETT
estimators. Conversely, overall mortality was significantly lower in larger hospitals after adjust-
ment among the robust ETT estimators; the TMLE and matching estimators yielded 8.3%
(95% CIs: (-13%, -3.3%)) and 17% (95% CIs: (-26%, -7.7%)) differences, respectively. We note
that the matching estimator excludes patients in large volume sites if they cannot be matched
with a patient in a small-volume site, and in this case 51 out of the 551 subjects at the large vol-
ume sites were found to be outside the p-score caliper of 0.05 standard deviations of any patient
at the small sites. Thus, the actual parameter estimated is not quite the ETT, but only the effect
among the subset of the population that can be matched. The advantage of this approach is
that this estimator avoids extrapolating the impact of site size from groups defined by the
covariates where there are insufficient numbers of large and small volume patients. The disad-
vantage is that the parameter is conditioned on a random subset, and thus its interpretation
could be problematic.
Plasma infusion volume differs significantly, and adjustment combined with the use of
robust estimators only modestly diminishes the estimated mean difference among those who
were treated at a large volume center, implying less confounding by characteristics in Table 1.
However, the volume of platelets infused is significantly different after adjustment using the
TMLE estimator, and marginally significant (or close to significance) with the matching esti-
mator. Thus, the robust semi-parametric (data-adaptive) estimators find important differences
among these hospitals that are not always apparent in simpler comparisons. This is due to both
Table 2. Difference in means, and adjusted ETT estimates (simple substitution, TMLE, and propensity score matching). 95% confidence intervals
are included in parentheses after each estimate. Asymptotic (normal-based) confidence intervals were calculated using the standard error of the Unadjusted,
Targeted Maximum-Likelihood, and Matching estimators. The nonparametric bootstrap was used to generate 95% confidence intervals in the case of the
Simple Substitution estimator.
ETT
Variable Unadjusted
Difference
Simple Subs.
(regression)
Simple Subs.
(SuperLearner)
TMLE Matching
2-hour mortality -0.014 (-0.035,
0.0071)
-0.017 (-0.041, 0.0084) -0.018 (-0.039, 0.0091) -0.016 (-0.039,
0.0078)
-0.029 (-0.071,
0.013)
6-hour mortality -0.0041 (-0.035,
0.027)
-0.016 (-0.050, 0.019) -0.031 (-0.071, 0.00097) -0.030 (-0.075,
0.014)
-0.10 (-0.17,
-0.035)
24-hour mortality -0.018 (-0.054, 0.018) -0.027 (-0.069, 0.018) -0.050 (-0.10, -0.010) -0.061 (-0.11,
-0.010)
-0.12 (-0.20,
-0.046)
Overall mortality -0.0066 (-0.052,
0.039)
-0.00083 (-0.044, 0.045) -0.0085 (-0.035, 0.054) -0.083 (-0.13,
-0.033)
-0.17 (-0.26,
-0.077)
Complications -0.030 (-0.055,
-0.0060)
-0.019 (-0.046, 0.0078) -0.022 (-0.045, 0.012) -0.010 (-0.033,
0.012)
-0.011 (-0.051,
0.028)
Multiple organ failure -0.0050 (-0.018,
0.0077)
0.0029 (-0.0081, 0.016) 0.0016 (-0.0056, 0.0095) 0.0045 (-0.0046,
0.014)
0.0047 (-0.015,
0.024)
Substantial bleeding 0.019 (-0.033, 0.071) 0.037 (-0.017, 0.093) 0.024 (-0.022, 0.079) -0.043 (-0.12, 0.030) -0.015 (-0.11,
0.081)
Plasma infused by 24 hr
(U)
3.1 (2.1, 4.2) 3.8 (2.8, 4.7) 3.3 (2.5, 4.6) 2.2 (0.74, 3.6) 2.1 (0.060, 4.0)
Platelets infused by 24 hr
(U)
0.30 (-0.61, 1.2) 1.2 (0.34, 2.0) 0.79 (0.062, 1.5) 1.1 (0.16, 2.1) 1.3 (-0.24, 2.8)
RBC infused by 24 hr (U) 0.68 (-0.52, 1.9) 1.5 (0.40, 2.8) 0.98 (0.27, 2.0) -0.21 (-2.0, 1.5) -0.46 (-2.8, 1.9)
Platelet:RBC ratio by 24
hr
-0.029 (-0.13, 0.071) 0.067 (-0.021, 0.15) 0.050 (-0.0056, 0.12) 0.058 (-0.043, 0.16) 0.11 (-0.034, 0.26)
Plasma:RBC ratio by 24
hr
0.47 (0.39, 0.55) 0.48 (0.40, 0.55) 0.46 (0.39, 0.53) 0.36 (0.26, 0.47) 0.35 (0.21, 0.49)
doi:10.1371/journal.pone.0136438.t002
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confounding and also misspecification when arbitrary modeling assumptions (e.g., main terms
logistic regression are used) are made.
Diagnostics
One of the challenges of using flexible, machine-learning tools is how to examine the fit of such
models, and also how to explore which variables have the greatest influence on the resulting
estimators. Though having a simple regression model that one can examine relatively easily in
more traditional approaches seems an advantage, it is generally illusory. Because a restricted
parametric model is likely to be misspecified, the resulting coefficients, for instance, are likely
to have unclear interpretations, so their attractiveness is more the appearance of simplicity
than the actual utility of interpretation [17]. An estimator like the TMLE, on the other hand,
allows for use of more flexible, nonparametric prediction models, is protected against misspeci-
fication of either the treatment mechanism or the conditional distribution of the outcome, and
uses the information in the data in the most efficient manner for estimating a target parameter.
One could consider as a downside of these techniques their reliance on “black-box” algorithms,
which, without further exploration, are not easily interpreted. However, below, we provide
some example tools for exploring the results reported in Table 2, which help to explain how
this automated, data-adaptive procedure results in the final estimates.
Effect of patient differences on overall mortality
We demonstrate these tools by examining the results for overall mortality. The goal is to identify
which patients have the biggest impact on the estimates of the ETT, and perhaps are those most
sensitive to any differences in practice at these clinics. To do so, we calculated “counterfactual”
residuals for each observation among those in the S = large clinics: Y—predicted(Y | S = small,
C), or the difference of the observed outcome and that predicted according to the resulting
model had the C stayed the same, but the clinic size switched from its observed value to “small.”
Positive residuals identify those subjects who have an estimated increase in outcome possibly
due to hospital-volume, while those with negative values display the opposite. One could group
or cluster the patients in various ways to examine if there are some patients that appear to have
been more affected by going to a small versus large-volume hospital. We did so by ordering the
patients using their predicted probability of death based on our SL model; this results in a mean-
ingful ranking of patients from those are lower to higher risk of the outcome based upon the
constellation of clinical and demographic factors. Specifically, a loess smooth of these residuals
versus simply their predicted outcome (in this case, predicted(Y | S = large, C)) was examined.
This allows one to estimate the difference in mortality due to volume versus patients on a scale
from lower to higher estimated risk of death. We repeat the converse of this for subjects from
smaller sites. The full results are presented in S1 and S2 Figs, for binary and continuous out-
comes, respectively, while Fig 1 displays a subset of the results contained in S1 Fig.
The top inset of Fig 1 gives schematics for what these plots might look like under three sce-
narios: 1) there is no difference in the estimated ETT for the outcome (two horizontal lines
close to the null line of 0), 2) there is a significant difference, but all patients are affected equally
(two horizontal lines away from the null line), and 3) some patients (in this case, patients at a
higher risk of death) are more affected by whether they end up at a large versus small volume
hospital. For those outcomes where the estimate of ETT was close to the null, both the large
and small volume hospital curves are near the null line at 0 (e.g., complications). For overall
mortality, among those individuals in smaller hospitals, those with greater estimated probabil-
ity of overall mortality appear to contribute the most to the estimate of greater increase in mor-
tality among smaller sites, though this difference gets smaller for the most severe (highest
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probability of death) patients. Though it is not appropriate to reference the 95% confidence
bands as reliable inference (given this is post-hoc), these exploratory plots provide a way to
decompose the estimated differences seen in Table 2.
In order to characterize the individuals whose mortality would have been most affected by a
site type change, we compared patients on either side of the point at which the loess curves
started to diverge from 0, an area highlighted in blue in S4 Fig. This identified 148 individuals
with negative residuals (survived) and 68 with positive residuals (died) who were treated at a
large volume site and were estimated to be most affected by a theoretical change from a small
to large volume site. These patients were then compared to the remaining large volume site
patients in the white area of S4 Fig—those on whom the site volume appeared to have, on aver-
age, less of an impact. Patients who were estimated to be most affected by the site change were
significantly more likely to be Black, had higher blunt injury rates, were more severely injured,
Fig 1. “Counterfactual” residual plot for binary outcomes. Residuals (see Diagnostics) for each outcome were plotted against probabilities of overall
mortality for large (dotted line) and small-volume (solid line) site patients for binary outcomes using loess smooths.
doi:10.1371/journal.pone.0136438.g001
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and were further from consciousness (S1 Table). They also had significantly longer partial
thromboplastin times, more severe base deficits, smaller INRs, and lower platelet counts (S1
Table). They were more likely to experience multiple organ failure and had higher transfusion
rates, as well as lower rates of transfused red blood cells relative to other blood products (S2
Table).
To further illuminate which types of patients were driving the estimated difference due to
hospital volume, we constructed a histogram of counterfactual predicted probabilities of mor-
tality, by site (S3 Fig). Patients from all sites span the entire range of probabilities, suggesting
that the curves fit to the residuals (Fig 1, S1 and S2 Figs) are not driven by only a few
individuals.
Propensity Score Matching Follow-up
In addition to the supplementary analysis on the subset of patients whose mortality probabili-
ties were estimated to be most impacted by a site type change, we explored the matched data
set generated by the propensity score procedure to determine whether the procedure achieved
balance in the covariates in the large versus small volume comparisons. The heatmap in Fig 2 is
a visualization of the entire matched data set where the data have been scaled to be comparable
across different variables. This procedure provides an exploration of the joint distribution of
variables across individuals to see if balance was achieved across the multivariate distribution
of adjustment variables. If the matching had not been successful, we would expect to see clus-
ters of individuals corresponding to groupings based on the hospital volume (large versus
small). While we see distinct clusters of individuals based on their covariate values, this appears
not to coincide with being in a large versus small volume site, suggesting that reasonable bal-
ance in the covariates (via propensity score matching) occurred.
Discussion
We here provide a general method for the objective comparison of the patient outcomes at dif-
ferent clinical sites using a parameter motivated by the causal inference literature and making
use of potentially automatable, machine-learning techniques for data-adaptive estimation. Our
data indicates that there are significant differences in outcomes based on the size of the site at
which a patient was treated. Treated in this manner the data suggests a mortality benefit for
those who were treated at centers that had the largest numbers of massively transfused patients.
Interestingly we show here that this difference arose primarily in patients in the middle of the
“prognostic” severity scale, that is, patients that neither had very low or very high estimated
probability of death based on baseline factors. Further exploration within this moderately
injured group of patients revealed both higher estimated probabilities of mortality and lower
estimated probabilities of being massively transfused if they had been treated at small-volume
sites (as opposed to large-volume sites), which supported the hypothesis that transfusion prac-
tices could be driving this observed mortality benefit. We subsequently found that the large-
volume patients who would have been most affected by being treated at a small-volume site
were indeed bleeding more and were generally worse off than their comparison group, which
could indicate a need for more aggressive and balanced transfusion practices.
Uncontrolled bleeding remains the single largest contributor to preventable 24-hour mor-
tality, making the rapid identification and treatment of hemorrhage after trauma critically
important [18]. Hence it is plausible that the centers with larger volumes more judiciously
identified those who were in need of early initiation of massive transfusion, which has been
shown in prior studies to improve mortality in patients with potentially survivable injuries
[19–21]. Large volume centers may have been able to respond earlier with a balanced
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transfusion, conferring an additional advantage. In contrast, those with nearly fatal or univer-
sally fatal injury were expected to die no matter what treatment they received.
Upon further investigation (presented in S1 Table), the patients who were less affected by
the site switch generally had higher Glasgow coma scores, lower injury severity scores, higher
Fig 2. Heatmap of matched data set with hierarchical clustering. A visualization of the scaled covariate values in the matched data set with hierarchical
clustering of the individual revealed little clustering of the individuals by site type, indicated in the bar on the left, suggesting that balance in the covariates was
achieved. The dendrogram on the right is the result of hierarchical clustering of the individuals based on their covariate values. The color bar on the left
indicates the site size where each individual was treated (purple corresponds to small-volume sites and blue to large-volume sites).
doi:10.1371/journal.pone.0136438.g002
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rates of penetrating injury, were less acidotic and less coagulopathic (evidenced by, on average,
shorter partial thromboplastin times and higher platelet counts). They also had lower probabil-
ities of some negative outcomes and generally required less transfusion of blood products (dis-
played in S2 Table). These data support the findings that those who are mildly injured are far
less likely to be suffering from catastrophic hemorrhage and will be more likely do well, regard-
less of the center. In any case, the results suggest a potential difference in average care in the
two groups of sites, which would motivate more finely collected data to highlight either hetero-
geneity in treatment that should be addressed, or differences in patient groups unaccounted for
in the variables in our analysis.
By estimating the ETT and adjusting for differences in patients across sites as aggressively as
possible, we were able to examine differences in the distribution of outcomes for patients at
large-volume trauma centers that might be related to heterogeneity in care across sites. This
process highlights the utility of the combination of machine learning and causal inference
modeling in clinical research and allows for a comparison that would have been infeasible in a
randomized experiment. The estimation of this comparison could be carried out using several
methods. We utilized machine learning approaches in both propensity score matching esti-
mates and those based on the outcome regression models. These approaches are advantageous
because they allow us to avoid relying on unnecessary modeling assumptions. For the majority
of the outcomes examined here, the direction of estimated effects from each of the four ETT
approaches was the same and the magnitudes were comparable, suggesting that each approach
was capturing some underlying differences between the centers. The unadjusted comparisons
demonstrate how a naïve approach to comparing the centers that does not adjust for patient
characteristics could miss some important outcomes that did in fact differ across the sites. Pro-
pensity score matching is another intuitive approach that can be used to generate counterfac-
tual outcomes for individuals by matching them to patients from other sites, and we showed
that balance was achieved in the covariates with a multivariate analysis of the matched data set.
These more commonly used approaches provided similar results to the TMLE, which is an esti-
mator designed to achieve the optimal bias-variance tradeoff and that has other desirable statis-
tical properties [14,22].
Such rigorous comparisons of center-level factors have the potential to be a useful tool for
identifying areas of improvement for individual centers and standardizing care across centers.
This is where further investigation can yield improvements in patient outcomes. In this case,
we partitioned the PROMMTT centers based on the number of patients they massively trans-
fused. All of the centers in PROMMTT are acknowledged to be leading high-quality level I
trauma centers and hence we understand that a limitation to this analysis is that the cutoff of
‘large volume’ vs. ‘small volume’ centers is somewhat arbitrary. Other partitions are possible,
and this general methodology would apply regardless of the choice. Ultimately, our results rep-
resent a proof of concept that that this approach can be used for any comparisons of hospital
care characteristics that are of clinical interest in the context of high-dimensional patient and
clinical measures.
The estimators implemented in this paper are more complex than other approaches, but
permit a less biased, machine-learning approach to estimation of both prognostic models and
resulting estimates of potential interventions. As in most observational clinical studies, it is
likely that we did not include all confounders of the effect volume on the outcomes of interest.
However, these data-adaptive approaches are so attractive because they optimize model/vari-
able selection in the context of high-dimensional patient information. This is by no means the
only approach to comparing patient outcomes at different hospitals. Indeed, additional com-
parisons could examine more closely what factors in particular are responsible for the differ-
ences in site effectiveness. Given the proliferation of interest in comparative effectiveness,
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familiarity with these data-adaptive (machine learning) causal inference methods will allow for
a better understanding of factors influencing trauma patient care and provide directions
towards other areas for improvement.
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S1 Table. Means and standard deviations of covariates in the subsets defined by the magni-
tude of residuals. Groups (large versus small) are defined in S4 Fig (in versus out of blue area).
P-value included for comparison (based on t-test or Pearson’s chi-square test for ordered ver-
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P-value included for comparison (based on t-test or Pearson’s chi-square test for ordered ver-
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S1 Fig. “Counterfactual” residual plot for binary outcomes. Residuals (see Diagnostics) for
each outcome were plotted against probabilities of overall mortality for large (dotted line) and
small-volume (solid line) site patients for binary outcomes using loess smooths.
(TIF)
S2 Fig. Counterfactual residual plot for continuous outcomes. Counterfactual residuals for
each outcome plotted against probabilities of overall mortality for large (dotted line) and
small-volume (solid line) site patients for continuous outcomes.
(TIF)
S3 Fig. Histogram of counterfactual predicted probabilities of overall mortality. Histogram
of the number of individuals supporting the loess curves in the residual plots in S1 and S2 Figs
colored by site membership. While there are more individuals at lower probabilities, there are
individuals from various sites across the entire range of probabilities suggesting that the loess
curves in the residual plots are not driven by only a few individuals.
(TIF)
S4 Fig. Patients driving the residuals for overall mortality. The blue area indicates where the
loess curves deviated from zero. We compared individuals with positive and negative residuals
in the large-volume subset.
(TIF)
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